BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 36937436)

  • 1. ImmuneScore of eight-gene signature predicts prognosis and survival in patients with endometrial cancer.
    Gu J; Wang Z; Wang BO; Ma X
    Front Oncol; 2023; 13():1097015. PubMed ID: 36937436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel five-gene metabolism-related risk signature for predicting prognosis and immune infiltration in endometrial cancer: A TCGA data mining.
    Huang H; Cai X; Lin J; Wu Q; Zhang K; Lin Y; Liu B; Lin J
    Comput Biol Med; 2023 Mar; 155():106632. PubMed ID: 36805217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of novel cell glycolysis related gene signature predicting survival in patients with endometrial cancer.
    Wang ZH; Zhang YZ; Wang YS; Ma XX
    Cancer Cell Int; 2019; 19():296. PubMed ID: 31807118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Construction of mRNA prognosis signature associated with differentially expressed genes in early stage of stomach adenocarcinomas based on TCGA and GEO datasets.
    Jiang F; Lin H; Yan H; Sun X; Yang J; Dong M
    Eur J Med Res; 2022 Oct; 27(1):205. PubMed ID: 36253873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lactate metabolism-related genes to predict the clinical outcome and molecular characteristics of endometrial cancer.
    Shi R; Li H; Wei S; Yu Z; Zhang J; Zhang Q; Zhou T; Yao Y; Zhang Q; Zhang T; Wang H
    BMC Cancer; 2023 May; 23(1):491. PubMed ID: 37259038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Construction of a novel mRNA-signature prediction model for prognosis of bladder cancer based on a statistical analysis.
    Li J; Cao J; Li P; Yao Z; Deng R; Ying L; Tian J
    BMC Cancer; 2021 Jul; 21(1):858. PubMed ID: 34315402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ER stress-related mRNA-lncRNA co-expression gene signature predicts the prognosis and immune implications of esophageal cancer.
    Li F; Ma J; Yan C; Qi Y
    Am J Transl Res; 2022; 14(11):8064-8084. PubMed ID: 36505280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An EMT-related genes signature as a prognostic biomarker for patients with endometrial cancer.
    Yu Y; Zhang Y; Li Z; Dong Y; Huang H; Yang B; Zhao E; Chen Y; Yang L; Lu J; Qiu F
    BMC Cancer; 2023 Sep; 23(1):879. PubMed ID: 37723477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Cholesterol Homeostasis-Related Gene Signature Predicts Prognosis of Endometrial Cancer and Correlates With Immune Infiltration.
    Chen Y; Lee K; Liang Y; Qin S; Zhu Y; Liu J; Yao S
    Front Genet; 2021; 12():763537. PubMed ID: 34790227
    [No Abstract]   [Full Text] [Related]  

  • 10. Identification and validation of autophagy-related prognostic signature for head and neck squamous cell carcinoma.
    Fang J; Yang Z; Xie J; Li Z; Hu C; Yang M; Zhou X
    Transl Oncol; 2021 Jul; 14(7):101094. PubMed ID: 33878525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Construction of a novel necroptosis-related lncRNA signature for prognosis prediction in esophageal cancer.
    Liu Y; Hao H; Kang L; Zheng G; Guo X; Li B; Zhao H; Hao H
    BMC Gastroenterol; 2022 Jul; 22(1):345. PubMed ID: 35840890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of a Novel Tumor Microenvironment-Associated Eight-Gene Signature for Prognosis Prediction in Lung Adenocarcinoma.
    Ma C; Luo H; Cao J; Zheng X; Zhang J; Zhang Y; Fu Z
    Front Mol Biosci; 2020; 7():571641. PubMed ID: 33102522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Significance of a PTEN Mutational Status-Associated Gene Signature in the Progression and Prognosis of Endometrial Carcinoma.
    Wu Y; Wang J; Ge L; Hu Q
    Oxid Med Cell Longev; 2022; 2022():5130648. PubMed ID: 35251475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Construction of a microenvironment immune gene model for predicting the prognosis of endometrial cancer.
    Wang Y; Zhang J; Zhou Y; Li Z; Lv D; Liu Q
    BMC Cancer; 2021 Nov; 21(1):1203. PubMed ID: 34763648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protein-based prognostic signature for predicting the survival and immunotherapeutic efficiency of endometrial carcinoma.
    Lai J; Xu T; Yang H
    BMC Cancer; 2022 Mar; 22(1):325. PubMed ID: 35337291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of Potential Crucial Genes Associated With the Pathogenesis and Prognosis of Endometrial Cancer.
    Liu L; Lin J; He H
    Front Genet; 2019; 10():373. PubMed ID: 31105744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Establishing a Prognostic Signature Based on Epithelial-Mesenchymal Transition-Related Genes for Endometrial Cancer Patients.
    Liu J; Cui G; Shen S; Gao F; Zhu H; Xu Y
    Front Immunol; 2021; 12():805883. PubMed ID: 35095892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of immune gene pair-based signature predictive of prognosis and immunotherapy in esophageal cancer.
    Cao K; Ma T; Ling X; Liu M; Jiang X; Ma K; Zhu J; Ma J
    Ann Transl Med; 2021 Oct; 9(20):1591. PubMed ID: 34790797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bioinformatic profiling identifies prognosis-related genes in the immune microenvironment of endometrial carcinoma.
    Cheng P; Ma J; Zheng X; Zhou C; Chen X
    Sci Rep; 2021 Jun; 11(1):12608. PubMed ID: 34131259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of cuproptosis-related subtypes, construction of a prognosis model, and tumor microenvironment landscape in gastric cancer.
    Wang J; Qin D; Tao Z; Wang B; Xie Y; Wang Y; Li B; Cao J; Qiao X; Zhong S; Hu X
    Front Immunol; 2022; 13():1056932. PubMed ID: 36479114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.